nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.693	1	CbGbCtD
Vismodegib—SHH—jaw skeleton—amyotrophic lateral sclerosis	0.0448	0.277	CbGeAlD
Vismodegib—SHH—forelimb—amyotrophic lateral sclerosis	0.0268	0.166	CbGeAlD
Vismodegib—SHH—appendage—amyotrophic lateral sclerosis	0.0207	0.128	CbGeAlD
Vismodegib—SHH—hindbrain—amyotrophic lateral sclerosis	0.011	0.0679	CbGeAlD
Vismodegib—SHH—embryo—amyotrophic lateral sclerosis	0.00686	0.0425	CbGeAlD
Vismodegib—SHH—brainstem—amyotrophic lateral sclerosis	0.00629	0.0389	CbGeAlD
Vismodegib—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0726	CcSEcCtD
Vismodegib—SMO—embryo—amyotrophic lateral sclerosis	0.0048	0.0297	CbGeAlD
Vismodegib—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00467	0.067	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0588	CcSEcCtD
Vismodegib—SHH—spinal cord—amyotrophic lateral sclerosis	0.00391	0.0242	CbGeAlD
Vismodegib—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0491	CcSEcCtD
Vismodegib—SHH—nervous system—amyotrophic lateral sclerosis	0.00329	0.0204	CbGeAlD
Vismodegib—SHH—central nervous system—amyotrophic lateral sclerosis	0.00317	0.0196	CbGeAlD
Vismodegib—SHH—cerebellum—amyotrophic lateral sclerosis	0.0031	0.0192	CbGeAlD
Vismodegib—SMO—medulla oblongata—amyotrophic lateral sclerosis	0.00307	0.019	CbGeAlD
Vismodegib—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0429	CcSEcCtD
Vismodegib—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0397	CcSEcCtD
Vismodegib—SMO—spinal cord—amyotrophic lateral sclerosis	0.00273	0.0169	CbGeAlD
Vismodegib—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0389	CcSEcCtD
Vismodegib—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0386	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0385	CcSEcCtD
Vismodegib—SHH—brain—amyotrophic lateral sclerosis	0.00252	0.0156	CbGeAlD
Vismodegib—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0334	CcSEcCtD
Vismodegib—SMO—nervous system—amyotrophic lateral sclerosis	0.0023	0.0143	CbGeAlD
Vismodegib—SMO—central nervous system—amyotrophic lateral sclerosis	0.00222	0.0137	CbGeAlD
Vismodegib—SMO—cerebellum—amyotrophic lateral sclerosis	0.00217	0.0134	CbGeAlD
Vismodegib—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00203	0.029	CcSEcCtD
Vismodegib—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0261	CcSEcCtD
Vismodegib—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0257	CcSEcCtD
Vismodegib—SMO—brain—amyotrophic lateral sclerosis	0.00176	0.0109	CbGeAlD
Vismodegib—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0252	CcSEcCtD
Vismodegib—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0249	CcSEcCtD
Vismodegib—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0247	CcSEcCtD
Vismodegib—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0219	CcSEcCtD
Vismodegib—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0219	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0217	CcSEcCtD
Vismodegib—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0206	CcSEcCtD
Vismodegib—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0204	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0191	CcSEcCtD
Vismodegib—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0185	CcSEcCtD
Vismodegib—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0182	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0181	CcSEcCtD
Vismodegib—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0181	CcSEcCtD
Vismodegib—Pain—Riluzole—amyotrophic lateral sclerosis	0.00125	0.018	CcSEcCtD
Vismodegib—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00125	0.018	CcSEcCtD
Vismodegib—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0172	CcSEcCtD
Vismodegib—ORM1—spinal cord—amyotrophic lateral sclerosis	0.0012	0.0074	CbGeAlD
Vismodegib—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0166	CcSEcCtD
Vismodegib—Etoricoxib—PTGS2—amyotrophic lateral sclerosis	0.00108	0.629	CrCbGaD
Vismodegib—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0151	CcSEcCtD
Vismodegib—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0149	CcSEcCtD
Vismodegib—ORM1—nervous system—amyotrophic lateral sclerosis	0.00101	0.00623	CbGeAlD
Vismodegib—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.001	0.0144	CcSEcCtD
Vismodegib—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00097	0.006	CbGeAlD
Vismodegib—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000931	0.0133	CcSEcCtD
Vismodegib—Rash—Riluzole—amyotrophic lateral sclerosis	0.000923	0.0132	CcSEcCtD
Vismodegib—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000922	0.0132	CcSEcCtD
Vismodegib—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00087	0.0125	CcSEcCtD
Vismodegib—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000803	0.00497	CbGeAlD
Vismodegib—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000716	0.00443	CbGeAlD
Vismodegib—ALB—brain—amyotrophic lateral sclerosis	0.000675	0.00418	CbGeAlD
Vismodegib—Sulfasalazine—PTGS2—amyotrophic lateral sclerosis	0.000635	0.371	CrCbGaD
Vismodegib—ABCB1—embryo—amyotrophic lateral sclerosis	0.00062	0.00384	CbGeAlD
Vismodegib—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000568	0.00351	CbGeAlD
Vismodegib—CYP2C8—brain—amyotrophic lateral sclerosis	0.000474	0.00294	CbGeAlD
Vismodegib—ABCG2—brain—amyotrophic lateral sclerosis	0.000461	0.00285	CbGeAlD
Vismodegib—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00042	0.0026	CbGeAlD
Vismodegib—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000405	0.0025	CbGeAlD
Vismodegib—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000396	0.00245	CbGeAlD
Vismodegib—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000353	0.00219	CbGeAlD
Vismodegib—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000298	0.00184	CbGeAlD
Vismodegib—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000286	0.00177	CbGeAlD
Vismodegib—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00028	0.00173	CbGeAlD
Vismodegib—ABCB1—brain—amyotrophic lateral sclerosis	0.000227	0.00141	CbGeAlD
Vismodegib—SHH—Disease—CST3—amyotrophic lateral sclerosis	0.000192	0.00261	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000187	0.00254	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000187	0.00254	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000181	0.00246	CbGpPWpGaD
Vismodegib—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000179	0.00243	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000178	0.00241	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000178	0.00241	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000177	0.0024	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000176	0.00239	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000176	0.00239	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000172	0.00234	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00017	0.0023	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000169	0.0023	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000167	0.00226	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000166	0.00226	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000165	0.00223	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000164	0.00223	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000161	0.00219	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000161	0.00219	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000161	0.00218	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000159	0.00216	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000158	0.00215	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000154	0.00209	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000153	0.00207	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000152	0.00207	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000152	0.00207	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000151	0.00205	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000151	0.00205	CbGpPWpGaD
Vismodegib—SHH—Disease—CASP9—amyotrophic lateral sclerosis	0.00014	0.0019	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000139	0.00189	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000138	0.00188	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000138	0.00188	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000136	0.00184	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000133	0.00181	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000132	0.00179	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000129	0.00176	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000129	0.00175	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.00171	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000126	0.00171	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000125	0.0017	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000124	0.00169	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000124	0.00168	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000123	0.00167	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000122	0.00165	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000121	0.00164	CbGpPWpGaD
Vismodegib—SHH—Disease—ERBB4—amyotrophic lateral sclerosis	0.000119	0.00162	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000118	0.0016	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000118	0.0016	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000117	0.00158	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000115	0.00157	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000115	0.00156	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000114	0.00155	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000113	0.00154	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000112	0.00151	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000111	0.00151	CbGpPWpGaD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00011	0.00149	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000109	0.00149	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000109	0.00148	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000109	0.00148	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000109	0.00148	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000109	0.00147	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000106	0.00144	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000105	0.00143	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000105	0.00142	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000105	0.00142	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000104	0.00141	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000103	0.00139	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000101	0.00138	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.0001	0.00136	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	9.99e-05	0.00136	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.9e-05	0.00134	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.78e-05	0.00133	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.73e-05	0.00132	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.68e-05	0.00131	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.68e-05	0.00131	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	9.65e-05	0.00131	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.55e-05	0.0013	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.28e-05	0.00126	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.27e-05	0.00126	CbGpPWpGaD
Vismodegib—SHH—Disease—APOE—amyotrophic lateral sclerosis	9.24e-05	0.00126	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.84e-05	0.0012	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	8.73e-05	0.00119	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	8.73e-05	0.00119	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.72e-05	0.00118	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.63e-05	0.00117	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.37e-05	0.00114	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.34e-05	0.00113	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.29e-05	0.00113	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	8.11e-05	0.0011	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	8.09e-05	0.0011	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.93e-05	0.00108	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	7.89e-05	0.00107	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.89e-05	0.00107	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.87e-05	0.00107	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	7.86e-05	0.00107	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	7.79e-05	0.00106	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.78e-05	0.00106	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.46e-05	0.00101	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.44e-05	0.00101	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	7.37e-05	0.001	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.2e-05	0.000977	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.1e-05	0.000964	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.02e-05	0.000954	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.95e-05	0.000944	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	6.9e-05	0.000937	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	6.82e-05	0.000926	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.78e-05	0.000921	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	6.78e-05	0.00092	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	6.78e-05	0.00092	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	6.76e-05	0.000918	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	6.74e-05	0.000915	CbGpPWpGaD
Vismodegib—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	6.74e-05	0.000915	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	6.62e-05	0.000899	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	6.61e-05	0.000898	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.59e-05	0.000895	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	6.51e-05	0.000884	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.47e-05	0.000879	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—amyotrophic lateral sclerosis	6.33e-05	0.00086	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.32e-05	0.000858	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	6.31e-05	0.000856	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.28e-05	0.000853	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	6.2e-05	0.000841	CbGpPWpGaD
Vismodegib—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	6.16e-05	0.000837	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.15e-05	0.000836	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.14e-05	0.000833	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	6.05e-05	0.000821	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	6.05e-05	0.000821	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.98e-05	0.000812	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.97e-05	0.000811	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.97e-05	0.000811	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.9e-05	0.000801	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.9e-05	0.000801	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	5.86e-05	0.000795	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	5.83e-05	0.000792	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.76e-05	0.000782	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.73e-05	0.000778	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.64e-05	0.000766	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	5.53e-05	0.000751	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	5.52e-05	0.00075	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	5.51e-05	0.000749	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	5.51e-05	0.000749	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	5.42e-05	0.000735	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.4e-05	0.000733	CbGpPWpGaD
Vismodegib—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	5.39e-05	0.000731	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.35e-05	0.000726	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.32e-05	0.000723	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.23e-05	0.000711	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.23e-05	0.000711	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.14e-05	0.000698	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.14e-05	0.000698	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.07e-05	0.000688	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	5.04e-05	0.000685	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.02e-05	0.000681	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	4.9e-05	0.000665	CbGpPWpGaD
Vismodegib—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	4.87e-05	0.000661	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.83e-05	0.000656	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.75e-05	0.000644	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.72e-05	0.000641	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.69e-05	0.000637	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.68e-05	0.000636	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.66e-05	0.000633	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.53e-05	0.000616	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	4.49e-05	0.00061	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.43e-05	0.000601	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.41e-05	0.000599	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	4.37e-05	0.000594	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	4.27e-05	0.000579	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.12e-05	0.000559	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.99e-05	0.000541	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.9e-05	0.00053	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.89e-05	0.000528	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.8e-05	0.000516	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	3.71e-05	0.000504	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.69e-05	0.000501	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.69e-05	0.000501	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.67e-05	0.000498	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.64e-05	0.000494	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.64e-05	0.000494	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.49e-05	0.000474	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	3.43e-05	0.000465	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.41e-05	0.000463	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.41e-05	0.000463	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.41e-05	0.000463	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.33e-05	0.000452	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	3.31e-05	0.00045	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.31e-05	0.00045	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.23e-05	0.000439	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.12e-05	0.000424	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.1e-05	0.000421	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.09e-05	0.00042	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	3.06e-05	0.000415	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.02e-05	0.00041	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.98e-05	0.000405	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.94e-05	0.000399	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.91e-05	0.000395	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.89e-05	0.000393	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.81e-05	0.000382	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.8e-05	0.00038	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.79e-05	0.000379	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.78e-05	0.000378	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.64e-05	0.000358	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.63e-05	0.000357	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.57e-05	0.000349	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.55e-05	0.000347	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.000345	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.51e-05	0.000341	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.5e-05	0.00034	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.45e-05	0.000333	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.44e-05	0.000331	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.32e-05	0.000315	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.29e-05	0.000311	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.29e-05	0.000311	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.24e-05	0.000304	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.18e-05	0.000297	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.09e-05	0.000284	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.99e-05	0.000271	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.84e-05	0.00025	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.84e-05	0.00025	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.76e-05	0.000239	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.75e-05	0.000237	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.57e-05	0.000213	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.51e-05	0.000205	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.51e-05	0.000205	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.51e-05	0.000205	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000204	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.43e-05	0.000194	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000189	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000188	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-05	0.000183	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.32e-05	0.000179	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-05	0.000171	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000168	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	0.000167	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.000164	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.14e-05	0.000155	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000155	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000154	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.000154	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000139	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	9.96e-06	0.000135	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	9.3e-06	0.000126	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.12e-06	0.00011	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.83e-06	0.000106	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.79e-06	0.000106	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.46e-06	0.000101	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.99e-06	9.49e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.82e-06	9.27e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.38e-06	8.66e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.14e-06	8.33e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.2e-06	5.71e-05	CbGpPWpGaD
